Roche Holding AG

Type: Company
Name: Roche Holding AG (Roche Holding Ltd)
Nationality: Switzerland
Web Address: http://www.roche.com/
Fact Sheet: Fact Sheet for Roche Holding AG
First reported 12 hours ago - Updated 3 hours ago - 2 reports

AstraZeneca steps up push into cancer immunotherapy | Reuters

8:54am EDT LONDON (Reuters) - AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumor types.The company is seen as No. 4 in a race to develop the first drug in a new class that fights cancer ... [Published DailyMe.Com - 8 hours ago]
First reported 21 hours ago - Updated 6 hours ago - 2 reports

Switzerland : Roche and AmorChem announce alliance focused on myotonic muscular dystrophy 1

Roche and AmorChem L.P. , a Montreal -based venture capital firm investing in life science projects, today announced they have entered into a collaboration to discover novel small molecule disease-modifying therapy for the treatment of myotonic muscular ... [Published HispanicBusiness.com - 6 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

Roche’s Sales Inch Up Slowly And Steadily

Roche Holdings (OTC:RHHBY) recently released its Q2 2014 results and re-affirmed its full year outlook. There was no surprise as cancer drugs, especially the newly launched ones, continued to drive its growth. The HER2 franchise grew stronger and there ... [Published Trefis - 9 hours ago]
First reported 15 hours ago - Updated 12 hours ago - 5 reports

Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina

DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Genomics Market 2014-2018" report to their offering.http://photos.prnewswire.com/prnh/20130307/600769Genomics is the study of the genetic material or ... [Published PR Newswire: General Business - 12 hours ago]
First reported Jul 30 2014 - Updated 13 hours ago - 2 reports

Bench International Appoints Dr Sally Barennes as Vice President, Executive Recruitment

As part of Bench International's one global team helping life science companies to find and retain transformative leaders, Dr Barennes is now responsible for business development, client relationships and search execution in Europe , and works as an active ... [Published 4 Traders - 13 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 1 reports

AstraZeneca and Roche to develop diagnostic test for lung cancer drug

:51 in Pharmaceutical Company Product News AstraZeneca is allying with Roche to create a companion diagnostic test to support AZD9291, its investigational compound in clinical development for non-small-cell lung cancer (NSCLC). The plasma-based companion ... [Published Zenopa - 15 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

When science and art intersect and provoke: Roche Continents challenge 100 students at the Salzburg Festival

Related Biotechnology, Pharmaceutical and Healthcare NewsFor the eighth time, Roche invites 100 students from all over the world to the Salzburg Festival for a series of creativity workshops during the “Roche Continents” week.Original Article: When science ... [Published BioPortfolio - 16 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Roche Gets European Approval For Leukemia Treatment Gazyvaro

07/30/14, Pharmaceutical Business Reviewbody: Swiss healthcare firm Roche has received approval from the European Commission for Gazyvaro in combination with chlorambucil chemotherapy to treat people with previously untreated chronic lymphocytic leukemia ... [Published AAPS Pharmceutica - 17 hours ago]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Hoffmann-La Roche Inc. v. Apotex Inc. (Fed. Cir.)

Case Name: Hoffmann-La Roche Inc. v. Apotex Inc. , 748 F.3d 1326 (Fed. Cir. Apr. 11, 2014) (Circuit Judges Newman, Lourie, and Bryson presiding; Opinion by Bryson, J.; Dissent by Newman, J.) (Appeal from D.N.J., Chesler, J.)Drug Product and Patent(s)-in-Suit: ... [Published JD Supra - Jul 31 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Roche forms a pharma alliance with AmorChem

Roche and AmorChem announced they have entered into a pharma alliance to discover novel small molecule disease-modifying therapy for the treatment of myotonic muscular dystrophy 1, or Steinert’s disease. Myotonic dystrophy is a progressive degenerative ... [Published BioPortfolio - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 5 reports

Research and Markets: Global Retinal Vein Occlusion Market 2014-2018: Key Vendors are Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5gl568/global_retinal) has announced the addition of the "Global Retinal Vein Occlusion Market 2014-2018" report to their offering. Retinal vein occlusion is a medical ... [Published Business Wire Health News - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 2 reports

As Pharma Jobs Leave N.J., Office Space Ghost Towns Remain

Audio for this story from Morning Edition will be available at approximately 9:00 a.m. "When this was a thriving site, this sidewalk would have been busy with folks walking up and down," says Darien Wilson, one of just 38 Roche employees still working ... [Published Austin American Statesman - Jul 30 2014]

Quotes

...Can you imagine the conversation at the bedside? Can you say to this patient: "You are not going to walk again, and we need you to accept that. We also need you to accept an experimental therapy." ?
The European Commission approved Veloxis Pharmaceuticals " (OMX:VELO) Envarsus for preventing organ rejection in adult kidney and liver transplant patients. Italian firm Chiesi Farmaceutici will commercialize the drug in the European Union. Release"
"We think there's a great opportunity for further consolidation in the industry," Chiminski told TheStreet. "... We have a very aggressive M&A program, I would say. We've done 5 deals in the last three years. We've got a pretty robust funnel of M&A going forward, and we think that we'll continue to pick up companies and bring them into the Catalent family over the next few years."

More Content

All (1714) | News (1442) | Reports (1) | Blogs (219) | Audio/Video (1) | Fact Sheets (27) | Press Releases (22)
sort by: Date | Relevance
Nektar Therapeutics' (NKTR) CEO Howard Robin on... [Published Seeking Alpha - 54 mins ago]
Christopher James Turns a Clinical Eye on Biote... [Published Stockboard Media Inc. - 2 hours ago]
FDA Oversight Granted to Genetic Testing for Th... [Published The Utah People's Post - 4 hours ago]
Senior Manager, Sponsorship & Development | Ame... [Published Associations Now Magazine - 4 hours ago]
Almirall seeks dermatology deals, Euro biotech ... [Published FierceBiotech - 5 hours ago]
Report: Increasing potential for in vitro diagn... [Published Center Watch - 5 hours ago]
Gene Tests to Match Patients to Therapy to Get ... [Published Washington Post - 6 hours ago]
Alnylam to Webcast Conference Call Discussing S... [Published Myrtle Beach Sun News - 6 hours ago]
Switzerland : Roche and AmorChem announce allia... [Published HispanicBusiness.com - 6 hours ago]
Catalent hauls in $871.3M in a super-sized IPO [Published Fierce CRO - 6 hours ago]
AstraZeneca steps up push into cancer immunothe... [Published DailyMe.Com - 8 hours ago]
FDA Advisory Committee Panel Provides Favorable... [Published Minyanville - 8 hours ago]
AstraZeneca dials up its immuno-oncology focus ... [Published FierceBiotech - 8 hours ago]
Neuroscience deals a no-brainer: VCJ [Published PE Hub Blog - 8 hours ago]
Cipher's Business Continues To Hum Along [Published Seeking Alpha - 9 hours ago]
West Coast Biotech Roundup: Amgen Layoffs, Aval... [Published Xconomy - 9 hours ago]
Roche’s Sales Inch Up Slowly And Steadily [Published Trefis - 9 hours ago]
Synageva BioPharma Reports Second Quarter 2014 ... [Published BioSpace - 9 hours ago]
AstraZeneca stocks respiratory and cancer pipel... [Published RSC - 10 hours ago]
TB Alliance Names Elana Robertson Senior Vice P... [Published Bio-Medicine - 10 hours ago]
Take the "Work" out of Networking at PCT Asia t... [Published Partnerships in Clinical Trials - 10 hours ago]
Omnichannel marketing for pharma [Published pharmaphorum - 11 hours ago]
Global Genomics Market 2014-2018: Key Vendors a... [Published PR Newswire: General Business - 12 hours ago]
AstraZeneca steps up push into cancer immunothe... [Published NewsRT.co.uk - 12 hours ago]
Bench International Appoints Dr Sally Barennes ... [Published 4 Traders - 13 hours ago]
Immunogen To Announce Mixed Fourth-Quarter Results [Published Bidness Etc - 13 hours ago]
The Galien Foundation Announces 2014 Prix Galie... [Published TickerTech.com - 13 hours ago]
TB Alliance Names Elana Robertson Senior Vice P... [Published TickerTech.com - 13 hours ago]
Research and Markets: Global Genomics Market 20... [Published Benzinga.com - 13 hours ago]
Research and Markets: Global Genomics Market 20... [Published Business Wire Science: Science News - 13 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Neuroscience deals a no-brainer: VCJ [Published PE Hub Blog - 8 hours ago]
Since the summer of 2013, an army of scientists has been scrambling to launch an all-out, decade-long, $3 billion research effort to map the human brain. They are responding to President Barack Obama’s call to build a large-scale simulation of how the ...
Take the "Work" out of Networking at PCT Asia t... [Published Partnerships in Clinical Trials - 10 hours ago]
Taking place September 16-18th at the Sheraton Shanghai Hongquio, Partnerships in Clinical Trials Asia , is the perfect mix of NEW content on the evolving landscape of clinical partnerships PLUS more networking opportunities than ever before!We guarantee ...
Global Genomics Market 2014-2018: Key Vendors a... [Published PR Newswire: General Business - 12 hours ago]
DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Genomics Market 2014-2018" report to their offering.http://photos.prnewswire.com/prnh/20130307/600769Genomics is the study of the genetic material or ...
Research and Markets: Global Genomics Market 20... [Published Business Wire Science: Science News - 13 hours ago]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/k2bz4m/global_genomics) has announced the addition of the "Global Genomics Market 2014-2018" report to their offering. Genomics is the study of the genetic material ...
Research and Markets: Global Genomics Market 20... [Published Business Wire Health News - 13 hours ago]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/k2bz4m/global_genomics) has announced the addition of the "Global Genomics Market 2014-2018" report to their offering. Genomics is the study of the genetic material ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Roche to pay $1.7bn for Seragon [Published Reuters Video: Business - Jul 02 2014]
1

Press Releases

sort by: Date | Relevance
Global Genomics Market 2014-2018: Key Vendors a... [Published GlobeNewswire: Acquisitions News - 15 hours ago]
Global Retinal Vein Occlusion Market 2014-2018:... [Published GlobeNewswire: Acquisitions News - Jul 30 2014]
Global Genomics and Proteomics Analytical Instr... [Published GlobeNewswire: Acquisitions News - Jul 24 2014]
OTC Markets Group Announces Second Quarter Perf... [Published OTC Markets Group Corporate News - Jul 17 2014]
Seragon Pharmaceuticals Announces Acquisition A... [Published GlobeNewswire: Acquisitions News - Jul 02 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.